Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal D Shore

Showing results (1-10 of 312) with videos related to

Pageof 32
Sort By:
Urology|May 5, 2011
Editorial commentNeal D Shore
Reviews in Urology|June 27, 2018
LUGPA Onsite and LUGPA Virtual Crossfire Programs Offer Novel Alternatives to Attending an Out-oftown LUGPA MeetingNeal D Shore
Reviews in Urology|November 27, 2018
LUGPA Celebrates Its 10th Anniversary at Its 2018 Annual MeetingNeal D Shore
Reviews in Urology|January 6, 2018
Practice management for urology groups: LUGPA's GuidebookNeal D Shore
Reviews in Urology|November 26, 2020
Current and Future Management of Locally Advanced and Metastatic Prostate CancerNeal D Shore
Immunotherapy|August 17, 2011
Phacilitate Barcelona active immunotherapeutics forum. 11-13 May 2011, Barcelona, SpainNeal D Shore
Reviews in Urology|January 28, 2017
Looking ahead to 2017Neal D Shore
European Urology Open Science|November 24, 2022
Reply to Juan Gómez Rivas, Giorgio Gandaglia, and Francesco Montorsi's Letter to the Editor re: Neal D. Shore, Joseph Renzulli, Neil E. Fleshner, et al. Enzalutamide Monotherapy vs Active Surveillance in Patients with Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial. JAMA Oncol 2022;8:1128-36Neal D Shore
Urology Practice|June 10, 2023
Editorial CommentaryNeal D Shore
Reviews in Urology|September 30, 2017
LUGPA newsNeal D Shore
Pageof 32

Showing results (1-10 of 312) with videos related to

Sort By:
Pageof 32
Urology|May 5, 2011
Editorial commentNeal D Shore
Reviews in Urology|June 27, 2018
LUGPA Onsite and LUGPA Virtual Crossfire Programs Offer Novel Alternatives to Attending an Out-oftown LUGPA MeetingNeal D Shore
Reviews in Urology|November 27, 2018
LUGPA Celebrates Its 10th Anniversary at Its 2018 Annual MeetingNeal D Shore
Reviews in Urology|January 6, 2018
Practice management for urology groups: LUGPA's GuidebookNeal D Shore
Reviews in Urology|November 26, 2020
Current and Future Management of Locally Advanced and Metastatic Prostate CancerNeal D Shore
Immunotherapy|August 17, 2011
Phacilitate Barcelona active immunotherapeutics forum. 11-13 May 2011, Barcelona, SpainNeal D Shore
Reviews in Urology|January 28, 2017
Looking ahead to 2017Neal D Shore
European Urology Open Science|November 24, 2022
Reply to Juan Gómez Rivas, Giorgio Gandaglia, and Francesco Montorsi's Letter to the Editor re: Neal D. Shore, Joseph Renzulli, Neil E. Fleshner, et al. Enzalutamide Monotherapy vs Active Surveillance in Patients with Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial. JAMA Oncol 2022;8:1128-36Neal D Shore
Urology Practice|June 10, 2023
Editorial CommentaryNeal D Shore
Reviews in Urology|September 30, 2017
LUGPA newsNeal D Shore
Pageof 32